Inflammation gene variants and susceptibility to albuminuria in the U.S. population: Analysis in the Third National Health and Nutrition Examination Survey (NHANES III), 1991-1994

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Ned, Renée M ^a   Yesupriya, Ajay ^a   Imperatore, Giuseppina ^b   Smelser, Diane T ^a,c   Moonesinghe, Ramal ^c   Chang, Man Huei ^a   Dowling, Nicole F ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; BIOLOGICAL MARKER;

ADULT; AFRICAN AMERICAN; ALBUMINURIA; ALLELE; ARTICLE; DIABETES MELLITUS; DNA POLYMORPHISM; ETHNICITY; EUROPEAN AMERICAN; FALSE POSITIVE RESULT; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; HAPLOTYPE; HEALTH SURVEY; HISPANIC; HUMAN; INFLAMMATION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; UNITED STATES; WAIST HIP RATIO; AGED; BIOLOGICAL MODEL; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; INFORMATION PROCESSING; KIDNEY DISEASE; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; BIOLOGICAL MARKERS; DATA COLLECTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; INFLAMMATION; KIDNEY DISEASES; MALE; MIDDLE AGED; MODELS, GENETIC; UNITED STATES; YOUNG ADULT;

EID: 78049364714     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-155     Document Type: Article

References (87)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298:2038-2047. 10.1001/jama.298.17.2038, 17986697.
2. Snyder JJ, Foley RN, Collins AJ. Prevalence of CKD in the United States: a sensitivity analysis using the National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 2009, 53:218-228. 10.1053/j.ajkd.2008.07.034, 2664624, 18950914.
3. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003, 108:2154-2169. 10.1161/01.CIR.0000095676.90936.80, 14581387.
4. Weir MR. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2007, 2:581-590. 10.2215/CJN.03190906, 17699466.
5. Danziger J. Importance of low-grade albuminuria. Mayo Clin Proc 2008, 83:806-812. 10.4065/83.7.806, 18613997.
6. Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, Engelgau M, Kusek JW, Byrd-Holt D, Narayan KM, Herman WH, et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002, 39:445-459. 10.1053/ajkd.2002.31388, 11877563.
7. de Zeeuw D, Parving HH, Henning RH. Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol 2006, 17:2100-2105. 10.1681/ASN.2006050517, 16825327.
8. Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. J Am Soc Nephrol 2006, 17:2106-2111. 10.1681/ASN.2005121288, 16825333.
9. Trepels T, Zeiher AM, Fichtlscherer S. The endothelium and inflammation. Endothelium 2006, 13:423-429. 10.1080/10623320601061862, 17169774.
10. Zernecke A, Weber C. Inflammatory mediators in atherosclerotic vascular disease. Basic Res Cardiol 2005, 100:93-101. 10.1007/s00395-005-0511-6, 15645164.
11. Barzilay JI, Peterson D, Cushman M, Heckbert SR, Cao JJ, Blaum C, Tracy RP, Klein R, Herrington DM. The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study. Am J Kidney Dis 2004, 44:25-34. 10.1053/j.ajkd.2004.03.022, 15211434.
12. Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 2000, 58:1703-1710. 10.1046/j.1523-1755.2000.00331.x, 11012904.
13. Kshirsagar AV, Bomback AS, Bang H, Gerber LM, Vupputuri S, Shoham DA, Mazumdar M, Ballantyne CM, Paparello JJ, Klemmer PJ. Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004). Am J Cardiol 2008, 101:401-406. 10.1016/j.amjcard.2007.08.041, 2848170, 18237609.
14. Navarro JF, Mora C, Maca M, Garca J. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis 2003, 42:53-61. 10.1016/S0272-6386(03)00408-6, 12830456.
15. Pannacciulli N, Cantatore FP, Minenna A, Bellacicco M, Giorgino R, De Pergola G. Urinary albumin excretion is independently associated with C-reactive protein levels in overweight and obese nondiabetic premenopausal women. J Intern Med 2001, 250:502-507. 10.1046/j.1365-2796.2001.00914.x, 11902818.
16. Schram MT, Chaturvedi N, Schalkwijk CG, Fuller JH, Stehouwer CD. Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study. Diabetologia 2005, 48:370-378. 10.1007/s00125-004-1628-8, 15692810.
17. Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD. C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk. Arterioscler Thromb Vac Biol 2002, 22:593-598.
18. Stehouwer CD, Gall MA, Twisk JW, Knudsen E, Emeis JJ, Parving HH. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes 2002, 51:1157-1165. 10.2337/diabetes.51.4.1157, 11916939.
19. Freedman BI, Bostrom M, Daeihagh P, Bowden DW. Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol 2007, 2:1306-1316. 10.2215/CJN.02560607, 17942768.
20. Ruster C, Wolf G. The role of chemokines and chemokine receptors in diabetic nephropathy. Front Biosci 2008, 13:944-955. 10.2741/2734, 17981602.
21. Zintzaras E, Papathanasiou AA, Stefanidis I. Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: a HuGE review and meta-analysis. Genet Med 2009, 11:695-706. 10.1097/GIM.0b013e3181b2046b, 19773668.
22. Nordfors L, Lindholm B, Stenvinkel P. End-stage renal disease--not an equal opportunity disease: the role of genetic polymorphisms. J Intern Med 2005, 258:1-12. 10.1111/j.1365-2796.2005.01516.x, 15953127.
23. National Health and Nutrition Examination Survey. , http://www.cdc.gov/nchs/nhanes.htm
24. NHANES III Data Files, Documentation, and SAS Code. , http://www.cdc.gov/nchs/nhanes/nh3data.htm
25. National Center for Health Statistics Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94 1994, Hyattsville, MD: National Center for Health Statistics, (Vital and Health Statistics, Series 1: Programs and Collection Procedures, no. 32) (DHHS publication no. (PHS) 94-1308) (GPO no. 017-022-01260-0), National Center for Health Statistics., http://www.cdc.gov/nchs/data/series/sr_01/sr01_032.pdf
26. NHANES Genetic Data. , http://www.cdc.gov/nchs/nhanes/genetics/genetic.htm
27. Chang M, Lindegren ML, Butler MA, Chanock SJ, Dowling NF, Gallagher M, Moonesinghe R, Moore CA, Ned RM, Reichler M, et al. Prevalence in the United States of Selected Candidate Gene Variants: Third National Health and Nutrition Examination Survey, 1991-1994. Am J Epidemiol 2009, 169:54-66. 10.1093/aje/kwn286, 2638878, 18936436.
28. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39:S1-266. 10.1016/S0272-6386(02)70081-4, 11904577.
29. Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, et al. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 2003, 111:1416-1421. 10.1542/peds.111.6.1416, 12777562.
30. Jacobs DR, Murtaugh MA, Steffes M, Yu X, Roseman J, Goetz FC. Gender- and race-specific determination of albumin excretion rate using albumin-to-creatinine ratio in single, untimed urine specimens: the Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol 2002, 155:1114-1119. 10.1093/aje/155.12.1114, 12048225.
31. The GeneCards Human Gene Database. , http://www.genecards.org
32. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000, 25:25-29. 10.1038/75556, 10802651.
33. Carbon S, Ireland A, Mungall CJ, Shu S, Marshall B, Lewis S. AmiGO: online access to ontology and annotation data. Bioinformatics 2009, 25:288-289. 10.1093/bioinformatics/btn615, 2639003, 19033274.
34. Yee YK, Chintalacharuvu SR, Lu J, Nagpal S. Vitamin D receptor modulators for inflammation and cancer. Mini Rev Med Chem 2005, 5:761-778. 10.2174/1389557054553785, 16101412.
35. Ridker PM, Pare G, Parker A, Zee RY, Danik JS, Buring JE, Kwiatkowski D, Cook NR, Miletich JP, Chasman DI. Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet 2008, 82:1185-1192. 10.1016/j.ajhg.2008.03.015, 2427311, 18439548.
36. Hwang SJ, Yang Q, Meigs JB, Pearce EN, Fox CS. A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study. BMC Med Genet 2007, 8(Suppl 1):S10. 10.1186/1471-2350-8-S1-S10, 1995611, 17903292.
37. Keebler ME, Sanders CL, Surti A, Guiducci C, Burtt NP, Kathiresan S. Association of Blood Lipids With Common DNA Sequence Variants at 19 Genetic Loci in the Multiethnic United States National Health and Nutrition Examination Survey III. Circ Cardiovasc Genet 2009, 2:238-243. 10.1161/CIRCGENETICS.108.829473, 20031591.
38. Crawford DC, Sanders CL, Qin X, Smith JD, Shephard C, Wong M, Witrak L, Rieder MJ, Nickerson DA. Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 2006, 114:2458-2465. 10.1161/CIRCULATIONAHA.106.615740, 17101857.
39. Chu AY, Parekh RS, Astor BC, Coresh J, Berthier-Schaad Y, Smith MW, Shuldiner AR, Kao WH. Association of APOE polymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic Study. BMC Med Genet 2009, 10:108. 10.1186/1471-2350-10-108, 2770999, 19852818.
40. Gunter EW, Lewis BG, Koncikowski SM. Laboratory Procedures Used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. 1996, National Center for Environmental Health and National Center for Health Statistics, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Atlanta, GA and Hyattsville, MD., http://www.cdc.gov/nchs/data/nhanes/nhanes3/cdrom/nchs/manuals/labman.pdf
41. Levey A, Coresh J, Greene T, Marsh J, Stevens L, Kusek J, Van Lente F. Expressing the MDRD study equation for estimating GFR with IDMS traceable (gold standard) serum creatinine values [abstract]. J Am Soc Nephrol 2005, 16:69A. abstract.
42. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007, 53:766-772. 10.1373/clinchem.2006.077180, 17332152.
43. National Kidney Disease Education Program (NKDEP). Laboratory Professionals: Equations and GFR Calculators. , http://www.nkdep.nih.gov/labprofessionals/equations_and_GFR.htm
44. Selvin E, Manzi J, Stevens LA, Van Lente F, Lacher DA, Levey AS, Coresh J. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis 2007, 50:918-926. 10.1053/j.ajkd.2007.08.020, 18037092.
45. Binder D. On the variance of asymptotically normal estimators from complex surveys. Int Stat Rev 1983, 51:279-292.
46. Woodruff R. A simple method for approximating the variance of a complicated estimate. J Am Stat Assoc 1971, 66:411-414.
47. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002, 53:79-91. 10.1159/000057986, 12037407.
48. Parsons VL. Using the Sampling Design in Logistic Regression Analysis of NCHS Survey Data-- Some Applications. Proceedings of the Survey Research Methods Section, American Statistical Association (ASA) 1992, 327-332. Alexandria, VA: American Statistical Association.
49. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001, 125:279-284. 10.1016/S0166-4328(01)00297-2, 11682119.
50. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological) 1995, 57:289-300.
51. Iyengar SK, Abboud HE, Goddard KA, Saad MF, Adler SG, Arar NH, Bowden DW, Duggirala R, Elston RC, Hanson RL, et al. Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes 2007, 56:1577-1585. 10.2337/db06-1154, 17363742.
52. Placha G, Canani LH, Warram JH, Krolewski AS. Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. Adv Chronic Kidney Dis 2005, 12:155-169. 10.1053/j.ackd.2005.02.002, 15822051.
53. Leon JM, Freedman BI, Miller MB, North KE, Hunt SC, Eckfeldt JH, Lewis CE, Kraja AT, Djousse L, Arnett DK. Genome scan of glomerular filtration rate and albuminuria: the HyperGEN study. Nephrol Dial Transplant 2007, 22:763-771. 10.1093/ndt/gfl674, 17189282.
54. Ioannidis JP, Trikalinos TA, Khoury MJ. Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. Am J Epidemiol 2006, 164:609-614. 10.1093/aje/kwj259, 16893921.
55. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009, 106:9362-9367. 10.1073/pnas.0903103106, 2687147, 19474294.
56. Hu BC, Chu SL, Wang GL, Gao PJ, Zhu DL, Wang JG. Association between genetic variation in transforming growth factors beta1 and beta3 and renal dysfunction in non-diabetic Chinese. Clin Exp Hypertens 2008, 30:121-131. 10.1080/10641960801931907, 18293167.
57. Dell'Omo G, Penno G, Pucci L, Lucchesi D, Del Prato S, Pedrinelli R. Lack of association between TGF-beta-1 genotypes and microalbuminuria in essential hypertensive men. Nephrol Dial Transplant 2009, 24:1864-1869. 10.1093/ndt/gfn754, 19176688.
58. Argano C, Duro G, Corrao S, Di Chiara T, Nuzzo D, Colomba D, Scaglione R, Licata G. Transforming growth factor beta1 T29C gene polymorphism and hypertension: relationship with cardiovascular and renal damage. Blood Press 2008, 17:220-226. 10.1080/08037050802431416, 18821144.
59. Liu Y, Burdon KP, Langefeld CD, Beck SR, Wagenknecht LE, Rich SS, Bowden DW, Freedman BI. T-786C polymorphism of the endothelial nitric oxide synthase gene is associated with albuminuria in the diabetes heart study. J Am Soc Nephrol 2005, 16:1085-1090. 10.1681/ASN.2004100817, 15743995.
60. Dell'Omo G, Penno G, Pucci L, Fotino C, Lucchesi D, Del Prato S, Pedrinelli R. Lack of association between endothelial nitric oxide synthase gene polymorphisms, microalbuminuria and endothelial dysfunction in hypertensive men. J Hypertens 2007, 25:1389-1395. 10.1097/HJH.0b013e3281268548, 17563560.
61. Hoffmann IS, Tavares-Mordwinkin R, Castejon AM, Alfieri AB, Cubeddu LX. Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J Hum Hypertens 2005, 19:233-240.
62. Nath SD, He X, Voruganti VS, Blangero J, MacCluer JW, Comuzzie AG, Arar NH, Abboud HE, Thameem F. The 27-bp repeat polymorphism in intron 4 (27 bp-VNTR) of endothelial nitric oxide synthase (eNOS) gene is associated with albumin to creatinine ratio in Mexican Americans. Mol Cell Biochem 2009, 331:201-205. 10.1007/s11010-009-0159-5, 19468830.
63. Ichikawa K, Konta T, Emi M, Toriyama S, Takasaki S, Ikeda A, Shibata Y, Takabatake N, Takeishi Y, Kato T, et al. Genetic polymorphisms of paraoxonase-1 are associated with chronic kidney disease in Japanese women. Kidney Int 2009, 76:183-189. 10.1038/ki.2009.97, 19357718.
64. Konta T, Emi M, Toriyama S, Ariumi H, Ishii M, Takasaki S, Ikeda A, Ichikawa K, Shibata Y, Takabatake N, et al. Association of CC chemokine ligand 5 genotype with urinary albumin excretion in the non-diabetic Japanese general population: the Takahata study. J Hum Genet 2008, 53:267-274. 10.1007/s10038-008-0246-6, 18217191.
65. Herrmann SM, Ringel J, Wang JG, Staessen JA, Brand E. Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study. Diabetes 2002, 51:2653-2657. 10.2337/diabetes.51.8.2653, 12145184.
66. Hsu CC, Kao WH, Coresh J, Pankow JS, Marsh-Manzi J, Boerwinkle E, Bray MS. Apolipoprotein E and progression of chronic kidney disease. JAMA 2005, 293:2892-2899. 10.1001/jama.293.23.2892, 15956634.
67. Hansen TK, Tarnow L, Thiel S, Steffensen R, Stehouwer CD, Schalkwijk CG, Parving HH, Flyvbjerg A. Association between mannose-binding lectin and vascular complications in type 1 diabetes. Diabetes 2004, 53:1570-1576. 10.2337/diabetes.53.6.1570, 15161763.
68. Kaunisto MA, Sjolind L, Sallinen R, Pettersson-Fernholm K, Saraheimo M, Frojdo S, Forsblom C, Fagerudd J, Hansen TK, Flyvbjerg A, et al. Elevated MBL concentrations are not an indication of association between the MBL2 gene and type 1 diabetes or diabetic nephropathy. Diabetes 2009, 58:1710-1714. 10.2337/db08-1495, 2699850, 19366862.
69. Miller WG, Bruns DE, Hortin GL, Sandberg S, Aakre KM, McQueen MJ, Itoh Y, Lieske JC, Seccombe DW, Jones G, et al. Current issues in measurement and reporting of urinary albumin excretion. Clin Chem 2009, 55:24-38. 10.1373/clinchem.2008.106567, 19028824.
70. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005, 67:2089-2100. 10.1111/j.1523-1755.2005.00365.x, 15882252.
71. Gansevoort RT, Verhave JC, Hillege HL, Burgerhof JG, Bakker SJ, de Zeeuw D, de Jong PE. The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int Suppl 2005, S28-35. 10.1111/j.1523-1755.2005.09408.x, 15752236.
72. Gaspari F, Perico N, Remuzzi G. Timed urine collections are not needed to measure urine protein excretion in clinical practice. Am J Kidney Dis 2006, 47:1-7. 10.1053/j.ajkd.2005.10.014, 16377379.
73. Kramer HM, Hsu CY, Curhan G. Need for sex-specific ACR. Am J Kidney Dis 2002, 40:435-436. author reply 437, 10.1053/ajkd.2002.35117, 12148123.
74. Mattix HJ, Hsu CY, Shaykevich S, Curhan G. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol 2002, 13:1034-1039.
75. Warram JH, Gearin G, Laffel L, Krolewski AS. Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 1996, 7:930-937.
76. Knight EL, Curhan GC. Albuminuria: moving beyond traditional microalbuminuria cut-points. Curr Opin Nephrol Hypertens 2003, 12:283-284. 10.1097/00041552-200305000-00009, 12698066.
77. Gonzalez JR, Carrasco JL, Dudbridge F, Armengol L, Estivill X, Moreno V. Maximizing association statistics over genetic models. Genet Epidemiol 2008, 32:246-254. 10.1002/gepi.20299, 18228557.
78. Lettre G, Lange C, Hirschhorn JN. Genetic model testing and statistical power in population-based association studies of quantitative traits. Genet Epidemiol 2007, 31:358-362. 10.1002/gepi.20217, 17352422.
79. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003, 41:1-12. 10.1053/ajkd.2003.50007, 12500213.
80. Krolewski AS, Poznik GD, Placha G, Canani L, Dunn J, Walker W, Smiles A, Krolewski B, Fogarty DG, Moczulski D, et al. A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int 2006, 69:129-136. 10.1038/sj.ki.5000023, 16374433.
81. Bamshad M. Genetic influences on health: does race matter?. JAMA 2005, 294:937-946. 10.1001/jama.294.8.937, 16118384.
82. Bamshad M, Wooding S, Salisbury BA, Stephens JC. Deconstructing the relationship between genetics and race. Nat Rev Genet 2004, 5:598-609. 10.1038/nrg1401, 15266342.
83. Sinha M, Larkin EK, Elston RC, Redline S. Self-reported race and genetic admixture. N Engl J Med 2006, 354:421-422. 10.1056/NEJMc052515, 16436780.
84. Tang H, Quertermous T, Rodriguez B, Kardia SL, Zhu X, Brown A, Pankow JS, Province MA, Hunt SC, Boerwinkle E, et al. Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet 2005, 76:268-275. 10.1086/427888, 1196372, 15625622.
85. Yang N, Li H, Criswell LA, Gregersen PK, Alarcon-Riquelme ME, Kittles R, Shigeta R, Silva G, Patel PI, Belmont JW, Seldin MF. Examination of ancestry and ethnic affiliation using highly informative diallelic DNA markers: application to diverse and admixed populations and implications for clinical epidemiology and forensic medicine. Hum Genet 2005, 118:382-392. 10.1007/s00439-005-0012-1, 16193326.
86. Houlihan CA, Tsalamandris C, Akdeniz A, Jerums G. Albumin to creatinine ratio: a screening test with limitations. Am J Kidney Dis 2002, 39:1183-1189. 10.1053/ajkd.2002.33388, 12046029.
87. Verhave JC, Hillege HL, de Zeeuw D, de Jong PE. How to measure the prevalence of microalbuminuria in relation to age and gender?. Am J Kidney Dis 2002, 40:436-437. author reply 437, 10.1053/ajkd.2002.35118, 12148124.